Copyright Reports & Markets. All rights reserved.

Global Inherited Cancer Genome Testing Market Growth (Status and Outlook) 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Inherited Cancer Genome Testing Market Size 2022-2028
    • 2.1.2 Inherited Cancer Genome Testing Market Size CAGR by Region
  • 2.2 Inherited Cancer Genome Testing Segment by Type
    • 2.2.1 Breast Cancer
    • 2.2.2 Lung Cancer
    • 2.2.3 Blood Cancer
    • 2.2.4 Liver Cancer
    • 2.2.5 Stomach Cancer
    • 2.2.6 Others
  • 2.3 Inherited Cancer Genome Testing Market Size by Type
    • 2.3.1 Global Inherited Cancer Genome Testing Market Size Market Share by Type (2022-2028)
    • 2.3.2 Global Inherited Cancer Genome Testing Market Size Growth Rate by Type (2022-2028)
  • 2.4 Inherited Cancer Genome Testing Segment by Application
    • 2.4.1 General Hospitals
    • 2.4.2 Specialty Clinics
  • 2.5 Inherited Cancer Genome Testing Market Size by Application
    • 2.5.1 Global Inherited Cancer Genome Testing Market Size Market Share by Application (2022-2028)
    • 2.5.2 Global Inherited Cancer Genome Testing Market Size Growth Rate by Application (2022-2028)

3 Inherited Cancer Genome Testing Key Players

  • 3.1 Date of Key Players Enter into Inherited Cancer Genome Testing
  • 3.2 Key Players Inherited Cancer Genome Testing Product Offered
  • 3.3 Key Players Inherited Cancer Genome Testing Funding/Investment Analysis
  • 3.4 Funding/Investment
    • 3.4.1 Funding/Investment by Regions
    • 3.4.2 Funding/Investment by End-Industry
  • 3.5 Key Players Inherited Cancer Genome Testing Valuation & Market Capitalization
  • 3.6 Key Players Mergers & Acquisitions, Expansion Plans
  • 3.7 Market Ranking
  • 3.8 New Product/Technology Launches
  • 3.9 Partnerships, Agreements, and Collaborations
  • 3.10 Mergers and Acquisitions

4 Inherited Cancer Genome Testing by Regions

  • 4.1 Inherited Cancer Genome Testing Market Size by Regions (2022-2028)
  • 4.2 United States Inherited Cancer Genome Testing Market Size Growth (2022-2028)
  • 4.3 China Inherited Cancer Genome Testing Market Size Growth (2022-2028)
  • 4.4 Europe Inherited Cancer Genome Testing Market Size Growth (2022-2028)
  • 4.5 Rest of World Inherited Cancer Genome Testing Market Size Growth (2022-2028)

5 United States

  • 5.1 United States Inherited Cancer Genome Testing Market Size by Type (2022-2028)
  • 5.2 United States Inherited Cancer Genome Testing Market Size by Application (2022-2028)

6 China

  • 6.1 China Inherited Cancer Genome Testing Market Size by Type (2022-2028)
  • 6.2 China Inherited Cancer Genome Testing Market Size by Application (2022-2028)

7 Europe

  • 7.1 Europe Inherited Cancer Genome Testing Market Size by Type (2022-2028)
  • 7.2 Europe Inherited Cancer Genome Testing Market Size by Application (2022-2028)

8 Rest of World

  • 8.1 Rest of World Inherited Cancer Genome Testing Market Size by Type (2022-2028)
  • 8.2 Rest of World Inherited Cancer Genome Testing Market Size by Application (2022-2028)
  • 8.3 Japan
  • 8.4 South Korea
  • 8.5 Southeast Asia

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Key Investors in Inherited Cancer Genome Testing

  • 10.1 Company A
    • 10.1.1 Company A Company Details
    • 10.1.2 Company Description
    • 10.1.3 Companies Invested by Company A
    • 10.1.4 Company A Key Development and Market Layout
  • 10.2 Company B
    • 10.2.1 Company B Company Details
    • 10.2.2 Company Description
    • 10.2.3 Companies Invested by Company B
    • 10.2.4 Company B Key Development and Market Layout
  • 10.3 Company C
    • 10.3.1 Company C Company Details
    • 10.3.2 Company Description
    • 10.3.3 Companies Invested by Company C
    • 10.3.4 Company C Key Development and Market Layout
  • 10.4 Company D
  • 10.5 ……

11 Key Players Analysis

  • 11.1 23andMe
    • 11.1.1 23andMe Company Details
    • 11.1.2 23andMe Inherited Cancer Genome Testing Product Offered
    • 11.1.3 23andMe Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.1.4 23andMe Main Business Overview
    • 11.1.5 23andMe News
  • 11.2 Agilent Technologies
    • 11.2.1 Agilent Technologies Company Details
    • 11.2.2 Agilent Technologies Inherited Cancer Genome Testing Product Offered
    • 11.2.3 Agilent Technologies Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.2.4 Agilent Technologies Main Business Overview
    • 11.2.5 Agilent Technologies News
  • 11.3 Bio-Rad Laboratories
    • 11.3.1 Bio-Rad Laboratories Company Details
    • 11.3.2 Bio-Rad Laboratories Inherited Cancer Genome Testing Product Offered
    • 11.3.3 Bio-Rad Laboratories Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.3.4 Bio-Rad Laboratories Main Business Overview
    • 11.3.5 Bio-Rad Laboratories News
  • 11.4 Centogene
    • 11.4.1 Centogene Company Details
    • 11.4.2 Centogene Inherited Cancer Genome Testing Product Offered
    • 11.4.3 Centogene Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.4.4 Centogene Main Business Overview
    • 11.4.5 Centogene News
  • 11.5 Color Genomics
    • 11.5.1 Color Genomics Company Details
    • 11.5.2 Color Genomics Inherited Cancer Genome Testing Product Offered
    • 11.5.3 Color Genomics Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.5.4 Color Genomics Main Business Overview
    • 11.5.5 Color Genomics News
  • 11.6 Gene By Gene
    • 11.6.1 Gene By Gene Company Details
    • 11.6.2 Gene By Gene Inherited Cancer Genome Testing Product Offered
    • 11.6.3 Gene By Gene Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.6.4 Gene By Gene Main Business Overview
    • 11.6.5 Gene By Gene News
  • 11.7 Illumina
    • 11.7.1 Illumina Company Details
    • 11.7.2 Illumina Inherited Cancer Genome Testing Product Offered
    • 11.7.3 Illumina Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.7.4 Illumina Main Business Overview
    • 11.7.5 Illumina News
  • 11.8 LabCorp
    • 11.8.1 LabCorp Company Details
    • 11.8.2 LabCorp Inherited Cancer Genome Testing Product Offered
    • 11.8.3 LabCorp Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.8.4 LabCorp Main Business Overview
    • 11.8.5 LabCorp News
  • 11.9 Myriad Genetics
    • 11.9.1 Myriad Genetics Company Details
    • 11.9.2 Myriad Genetics Inherited Cancer Genome Testing Product Offered
    • 11.9.3 Myriad Genetics Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.9.4 Myriad Genetics Main Business Overview
    • 11.9.5 Myriad Genetics News
  • 11.10 Positive Bioscience
    • 11.10.1 Positive Bioscience Company Details
    • 11.10.2 Positive Bioscience Inherited Cancer Genome Testing Product Offered
    • 11.10.3 Positive Bioscience Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.10.4 Positive Bioscience Main Business Overview
    • 11.10.5 Positive Bioscience News
  • 11.11 Quest Diagnostics
  • 11.12 Thermo Fisher Scientific

12 Research Findings and Conclusion

According to this study, the global Inherited Cancer Genome Testing market size will reach US$ million by 2028.

This report presents a comprehensive overview, market shares, and growth opportunities of Inherited Cancer Genome Testing market by product type, application, key players and key regions and countries.

Segmentation by product type:
Breast Cancer
Lung Cancer
Blood Cancer
Liver Cancer
Stomach Cancer
Others

Segmentation by Application:
General Hospitals
Specialty Clinics

This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
23andMe
Agilent Technologies
Bio-Rad Laboratories
Centogene
Color Genomics
Gene By Gene
Illumina
LabCorp
Myriad Genetics
Positive Bioscience
Quest Diagnostics
Thermo Fisher Scientific
Buy now